| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 120.71B | 119.15B | 102.66B | 108.81B | 94.58B | 87.31B |
| Gross Profit | 32.62B | 33.58B | 26.96B | 28.69B | 22.68B | 19.03B |
| EBITDA | 19.02B | 18.71B | 13.50B | 14.86B | 10.72B | 8.06B |
| Net Income | 11.95B | 12.10B | 7.51B | 8.10B | 5.59B | 3.68B |
Balance Sheet | ||||||
| Total Assets | 133.36B | 138.53B | 138.86B | 129.34B | 118.68B | 111.21B |
| Cash, Cash Equivalents and Short-Term Investments | 8.99B | 10.22B | 9.57B | 9.49B | 8.73B | 12.36B |
| Total Debt | 15.06B | 14.96B | 21.82B | 22.03B | 21.86B | 23.95B |
| Total Liabilities | 54.33B | 58.40B | 64.41B | 66.72B | 64.59B | 59.85B |
| Stockholders Equity | 79.03B | 80.13B | 74.45B | 62.61B | 54.09B | 51.35B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.40B | 3.11B | 2.23B | 1.57B | 3.95B |
| Operating Cash Flow | 0.00 | 11.37B | 9.84B | 6.03B | 2.95B | 6.81B |
| Investing Cash Flow | 0.00 | -1.92B | -7.50B | -4.06B | -1.85B | -2.91B |
| Financing Cash Flow | 0.00 | -8.96B | -2.36B | -1.28B | -4.76B | 843.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥364.76B | 25.54 | ― | 1.01% | 14.47% | 30.85% | |
75 Outperform | ¥343.11B | 14.76 | ― | 2.50% | 6.16% | 17.11% | |
73 Outperform | ¥301.10B | 14.24 | ― | 1.65% | 14.49% | -21.17% | |
71 Outperform | ¥543.81B | 28.49 | 5.25% | 2.13% | -2.23% | 130.96% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥379.28B | 197.68 | 5.94% | 0.56% | 6.22% | ― | |
55 Neutral | ¥595.28B | -6.48 | 1.88% | 6.16% | 1.98% | -48.28% |